4th Annual Peptides Congress 2017

Oxford Global Conferences are proud to announce the 4th Annual Peptides Congress, taking place on 24 – 25 April 2017 in London, UK. This highly anticipated conference provides a unique opportunity for over 400 senior-level delegates to engage in scientific discussions about the current research results and latest advancements that help the industry going forward.Over 25 presentations and case studies focusing on the key advancements in peptides technologies, chemistry, formulation & delivery as well as peptide therapeutics.

- Recent Progress in Peptide Technologies & Manufacturing

- Peptide Discovery & Development: Peptide Chemistry, Formulation & Delivery

- Advances in Peptide Therapeutics

The 2017 Peptides Congress features a revamped conference agenda that will focus on peptide technologies & manufacturing as well as peptide chemistry, formulation & delivery on Day 1. Stream 1 will feature presentations covering recent progress in peptide synthesis, advancements in peptide screening as well as updates in peptide stabilisation and efficient manufacturing of peptides. In Stream 2 our highly acknowledged speakers will focus on such hot topic areas as utilising macrocyclic peptides in drug discovery, novel strategies for peptide formulation and devices for the effective delivery of peptides. The areas of enhancing the immunogenicity of peptides as well as peptide analysis & quantification will also be addressed. 

Day 2 of the event will focus on peptide therapeutics. Novel case studies from exciting research areas such as diabetes, metabolic diseases and well as abdominal pain disorders will be covered. Renowned experts will also deliver talks on peptide drug conjugates, peptide-based vaccines and immunotherapies.

Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

Confirmed Speakers 2017 Include:

- Joël Richard, Senior Vice President, Peptides, Head of CMC Development Dreux Site, Ipsen

- Lotte Bjerre Knudsen, Scientific Vice President and Senior Principal Scientist, Novo Nordisk A/S

- Lutz Jermutus, Senior Director, Product Development Team Leader, Cardiovascular & Metabolic Diseases iMED, MedImmune

- Renuka Pillutla, Executive Director, Bioanalytical Analysis, Bristol-Myers Squibb

- Paul Carrington, Director, Biology – Discovery, Merck Sharp & Dohme Corp.

- Les Miranda, Director Research, Therapeutic Discovery, Amgen

- Edwin Romijn, Associate Director NMR/MS, Janssen

- Eric Valeur, Associate Director New Modalities, AstraZeneca